European Union · Record · QUESTION_WRITTEN_PRIORITY
P-8-2014-005725
Authorisation of off-label use of bevacizumab for economic reasons
Introduced
11 July 2014
Last action
—
Status
QUESTION_WRITTEN_PRIORITY
Sponsors
—
Subjects
Discovery layer
Source updated
11 July 2014
Official titles
Authentic titles published by the source. The stored canonical title is not replaced.
1 official language
English
Authorisation of off-label use of bevacizumab for economic reasons
Records
Official record P-8-2014-005725 from European Union at European Parliament. Dated 11 July 2014. Status: QUESTION_WRITTEN_PRIORITY.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
11 official files
Authorisation of off-label use of bevacizumab for economic reasons
Authorisation of off-label use of bevacizumab for economic reasons
QUESTION_WRITTEN_PRIORITY · EN · 8 June 2018
Authorisation of off-label use of bevacizumab for economic reasons
QUESTION_WRITTEN_PRIORITY · EN · 8 June 2018
Authorisation of off-label use of bevacizumab for economic reasons
QUESTION_WRITTEN_PRIORITY · EN · 8 June 2018
Authorisation of off-label use of bevacizumab for economic reasons
QUESTION_WRITTEN_PRIORITY · EN · 8 June 2018
Authorisation of off-label use of bevacizumab for economic reasons
QUESTION_WRITTEN_PRIORITY · EN · 8 June 2018
Answer
QUESTION_WRITTEN_ANSWER
Autorisation de l'utilisation hors AMM (autorisation de mise sur le marché) du bevacizumab pour des raisons économiques
QUESTION_WRITTEN_PRIORITY · FR · 8 June 2018
Autorisation de l'utilisation hors AMM (autorisation de mise sur le marché) du bevacizumab pour des raisons économiques
QUESTION_WRITTEN_PRIORITY · FR · 8 June 2018
Autorisation de l'utilisation hors AMM (autorisation de mise sur le marché) du bevacizumab pour des raisons économiques
QUESTION_WRITTEN_PRIORITY · FR · 8 June 2018
Autorisation de l'utilisation hors AMM (autorisation de mise sur le marché) du bevacizumab pour des raisons économiques
QUESTION_WRITTEN_PRIORITY · FR · 8 June 2018
Autorisation de l'utilisation hors AMM (autorisation de mise sur le marché) du bevacizumab pour des raisons économiques
QUESTION_WRITTEN_PRIORITY · FR · 8 June 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.